Lidocaine Hydrochloride Injection, Solution
Product Images NDC 55150-251

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride (NDC 55150-251). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (1% 100 mg per 10 mL (10 mg/mL))

Package Label-principal Display Panel (1% 100 mg per 10 mL (10 mg/mL))
Label for Lidocaine Hydrochloride Injection, USP 1% (10 mg/mL) in a 10 mL multiple-dose vial by Eugia US LLC. Suitable for infiltration and nerve block, with storage instructions and warnings against use if discolored. Manufactured in India for Eugia US LLC.*
FDA Label Image

Package Label-principal Display Panel (1% 100 mg per 10 mL (10 mg/mL))

Package Label-principal Display Panel (1% 100 mg per 10 mL (10 mg/mL))
Packaging label for Lidocaine Hydrochloride 1% (10 mg/mL) Injection, USP. The label indicates 100 mg per 10 mL in multiple-dose vials, sterile and nonpyrogenic, for infiltration and nerve block, not for caudal or epidural use. It is labeled as Rx only with methylparaben as a preservative. The labeler is Eugia US LLC.*
FDA Label Image

Package Label-principal Display Panel (1% 200 mg per 20 mL (10 mg/mL))

Package Label-principal Display Panel (1% 200 mg per 20 mL (10 mg/mL))
Label of Lidocaine Hydrochloride Injection, USP 10 mg/mL (1%) solution in a 20 mL multiple-dose vial by Eugia US LLC. The label states 200 mg per 20 mL for infiltration and nerve block use, with a warning against caudal or epidural use. It includes storage instructions and manufacturing information.*
FDA Label Image

Package Label-principal Display Panel (1% 200 mg per 20 mL (10 mg/mL))

Package Label-principal Display Panel (1% 200 mg per 20 mL (10 mg/mL))
Label for Lidocaine Hydrochloride 1% Injection, USP, 200 mg per 20 mL (10 mg/mL), multiple-dose vials. The label states it is sterile, nonpyrogenic, for infiltration and nerve block use, not for caudal or epidural use. Methylparaben is included as a preservative. Distributed by Eugia US LLC, made in India.*
FDA Label Image

Package Label-principal Display Panel (2% 200 mg per 10 mL (20 mg/mL))

Package Label-principal Display Panel (2% 200 mg per 10 mL (20 mg/mL))
Lidocaine Hydrochloride 20 mg/mL (2%) Injection, USP solution. The label states 200 mg per 10 mL multiple-dose vial, for infiltration and nerve block use. It is marked Rx only and manufactured by Eugia US LLC. Storage instructions specify 20° to 25°C, with methylparaben as preservative. Barcodes and caution notes about solution use and sterilization are also visible.*
FDA Label Image

Package Label-principal Display Panel (2% 200 mg per 10 mL (20 mg/mL))

Package Label-principal Display Panel (2% 200 mg per 10 mL (20 mg/mL))
Packaging label for Lidocaine Hydrochloride 2% Injection, USP, 200 mg per 10 mL (20 mg/mL) solution. The sterile, nonpyrogenic injection is presented in multiple-dose vials of 25 x 10 mL. The label indicates use for infiltration and nerve block and cautions that it is not for caudal or epidural use. Methylparaben is used as a preservative. Distributed by Eugia US LLC.*
FDA Label Image

Package Label-principal Display Panel (2% 400 mg per 20 mL (20 mg/mL))

Package Label-principal Display Panel (2% 400 mg per 20 mL (20 mg/mL))
Label for Lidocaine Hydrochloride Injection USP, 20 mg/mL (2%) solution, 20 mL multiple-dose vial. It indicates use for infiltration and nerve block, not for caudal or epidural use. The product is sterile, nonpyrogenic, contains methylparaben as a preservative, and is manufactured in India for Eugia US LLC.*
FDA Label Image

Package Label-principal Display Panel (2% 400 mg per 20 mL (20 mg/mL))

Package Label-principal Display Panel (2% 400 mg per 20 mL (20 mg/mL))
Packaging label for Lidocaine HCl Injection, USP 2% (20 mg/mL) by Eugia US LLC. The label indicates 400 mg per 20 mL in multiple-dose vials (25 x 20 mL). It is sterile, nonpyrogenic and intended for infiltration and nerve block, not for caudal or epidural use. Additional details include preservatives and storage instructions.*
FDA Label Image

Chemical-structure (Lidocaine Str)

Chemical-structure (Lidocaine Str)
Chemical structure diagram of Lidocaine Hydrochloride showing its molecular formula including aromatic, amide, and amine functional groups along with the hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.